H Ørjasæter
- Co-authors
- P BrandtzægL TheodorsenEgil JellumPer G. Lund‐LarsenTorleiv O. RognumK. ElgjoA AndersenErik Thorud
- Topics
- Glycosylation and Glycoproteins Research (8 papers)Monoclonal and Polyclonal Antibodies Research (7 papers)Blood groups and transfusion (6 papers)
In The Last Decade
H Ørjasæter
41 papers receiving 449 citations
Peers
Comparison fields: 5 of 78
- Oncology 135
- Molecular Biology 112
- Epidemiology 102
- Cancer Research 97
- Pathology and Forensic Medicine 88
Countries citing papers authored by H Ørjasæter
This map shows the geographic impact of H Ørjasæter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H Ørjasæter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H Ørjasæter more than expected).
Fields of papers citing papers by H Ørjasæter
This network shows the impact of papers produced by H Ørjasæter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H Ørjasæter. The network helps show where H Ørjasæter may publish in the future.
Co-authorship network of co-authors of H Ørjasæter
This figure shows the co-authorship network connecting the top 25 collaborators of H Ørjasæter. A scholar is included among the top collaborators of H Ørjasæter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H Ørjasæter. H Ørjasæter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 24 | |
| 2 | 20 | |
| 3 | 66 | |
| 4 | 25 | |
| 5 | 12 | |
| 6 | 33 | |
| 7 | 4 | |
| 8 | Plasma CEA in large bowel carcinoma: which patients should be followed by regular postoperative measurements? Preliminary follow-up results in 100 patients with different tumor DNA-ploidy patterns. | 5 |
| 9 | 4 | |
| 10 | 46 | |
| 11 | Carcinoembryonic antigen in the diagnosis and follow-up of colorectal carcinoma. | 2 |
| 12 | 10 | |
| 13 | 1 | |
| 14 | The "Janus" serum research programme: a multipurpose project for retrospective as well as prospective investigations of cancer. | 2 |
| 15 | 19 | |
| 16 | 10 | |
| 17 | 7 | |
| 18 | 4 | |
| 19 | 1 | |
| 20 | 2 |
About H Ørjasæter
H Ørjasæter is a scholar working on Hematology, Management of Technology and Innovation and Hepatology, having authored 41 papers that have together received 510 indexed citations. Recurring topics across this work include Glycosylation and Glycoproteins Research (8 papers), Monoclonal and Polyclonal Antibodies Research (7 papers) and Blood groups and transfusion (6 papers). The work is most often cited by research in Management of Technology and Innovation (46 citations), Cancer Research (97 citations) and Oncology (135 citations). H Ørjasæter has collaborated with scholars based in Norway, Laos and India. Frequent co-authors include P Brandtzæg, L Theodorsen, Egil Jellum, Per G. Lund‐Larsen, Torleiv O. Rognum, K. Elgjo, A Andersen, Erik Thorud, K. Nygaard and R. Nordhagen. Their work appears in journals such as Nature, The Science of The Total Environment and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.